Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Angioedema Type I and II”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Testing effectiveness (Phase 2)Study completedNCT04618211
What this trial is testing

Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+7 more
Pharvaris Netherlands B.V. 74
Not applicableStudy completedNCT03558009
What this trial is testing

Epidemiological Analysis for Hereditary Angioedema Disease

Who this might be right for
Abdominal PainFunctional Abdominal Pain
CENTOGENE GmbH Rostock 2,318
Large-scale testing (Phase 3)Study completedNCT02316353
What this trial is testing

Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 126
Large-scale testing (Phase 3)Study completedNCT01912456
What this trial is testing

Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 90
Testing effectiveness (Phase 2)Study completedNCT05047185
What this trial is testing

Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+7 more
Pharvaris Netherlands B.V. 34
Large-scale testing (Phase 3)Study completedNCT03472040
What this trial is testing

A Long Term Safety Study of BCX7353 in Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaHAEProphylaxis
BioCryst Pharmaceuticals 387
Not applicableStudy completedNCT03029728
What this trial is testing

Biomarker for Hereditary AngioEdema Disease

Who this might be right for
C1 Esterase Inhibitor DeficiencyAngio EdemaC4 Deficiency+5 more
CENTOGENE GmbH Rostock 42
Not applicableStudy completedNCT04130191
What this trial is testing

Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II

Who this might be right for
Hereditary Angioedema (HAE)
Shire 140
Not applicableUnknownNCT03828279
What this trial is testing

Global Registry to Gather Data on Natural History of Patients With Hereditary Angioedema Type I and II

Who this might be right for
Hereditary Angioedema Type I and II
HAE Global Registry Foundation 220
Large-scale testing (Phase 3)Study completedNCT00997204
What this trial is testing

EASSI - Evaluation of the Safety of Self-Administration With Icatibant

Who this might be right for
Hereditary Angioedema
Shire 151
Large-scale testing (Phase 3)Study completedNCT00912093
What this trial is testing

Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)

Who this might be right for
Hereditary Angioedema
Shire 98
Not applicableStudy completedNCT03845400
What this trial is testing

Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II in North America

Who this might be right for
Hereditary Angioedema (HAE)
Shire 168
Testing effectiveness (Phase 2)Study completedNCT01576523
What this trial is testing

Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 18
Testing effectiveness (Phase 2)Study completedNCT00119431
What this trial is testing

Kinetics, Efficacy and Safety of C1-Esteraseremmer-N

Who this might be right for
Hereditary Angioedema Type IAngioneurotic Edema
Prothya Biosolutions 12
Large-scale testing (Phase 3)Enrolling By InvitationNCT05396105
What this trial is testing

Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+12 more
Pharvaris Netherlands B.V. 140
Not applicableActive Not RecruitingNCT05469789
What this trial is testing

Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 50
Large-scale testing (Phase 3)Study completedNCT06343779
What this trial is testing

Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+11 more
Pharvaris Netherlands B.V. 134
Testing effectiveness (Phase 2)Ended earlyNCT05055258
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of Different Doses of KVD824 for Prophylactic Treatment of HAE Type I or II

Who this might be right for
Angioedema, Hereditary, Types I and II
KalVista Pharmaceuticals, Ltd. 33
Testing effectiveness (Phase 2)Study completedNCT04208412
What this trial is testing

A Phase II, Cross-over Clinical Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) in the On-demand Treatment of Angioedema Attacks in Adult Subjects With Hereditary Angioedema Type I or II

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 84
Large-scale testing (Phase 3)Active Not RecruitingNCT05511922
What this trial is testing

PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 11
Load More Results